Nuclear-cytoplasmic PARP-1 expression as an unfavorable prognostic marker in lymph nodenegative early breast cancer: 15-year follow-up

Author：

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.31, Iss.4, 2014-01, pp. : 1777-1787

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer

By Jonsdottir Kristin Zhang Hui Jhagroe Darshni Skaland Ivar Slewa Aida Björkblom Benny Coffey Eleanor Gudlaugsson Einar Smaaland Rune Janssen Emiel Baak Jan

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 381-390

Springer Publishing Company

Access to resources Recommend Favorite

Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse

By Harbeck N.

Breast Cancer Research and Treatment, Vol. 54, Iss. 2, 1999-03 ,pp. : 147-157

Springer Publishing Company

Access to resources Recommend Favorite

A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance

By Wernicke A.

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 893-902

Springer Publishing Company

Access to resources Recommend Favorite

Expression and prognostic value of plasminogen activator inhibitor type 1 in node-negative breast cancer

By Wang Bin

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 6, 2008-06 ,pp. : 339-343

Springer Publishing Company

Access to resources Recommend Favorite